Anemia is a prevalent yet underrecognized and undertreated condition that imposes
substantial costs to payers1, 2 and negative consequences on the health and quality of life …

OBJECTIVE: Anemia is a common hematological disorder characterized by reduced
hemoglobin concentrations. Despite information on prevalence and associated outcomes …

OBJECTIVE: To examine the economic impact of patients with anemia in selected diseases.
METHODS: A retrospective cohort design was used to estimate the differences in costs …

In this issue of Blood, Kassebaum et al estimate that the global anemia prevalence in 2010
was 32.9%, resulting in 68.4 million years lived with disability (YLD). 1 The results …

Anemia of chronic disease is a hypoproliferative ane-mia that develops in response to
systemic illness or inflammation. 1 It was first described in the 1930s and was more fully …

Anemia is not considered a serious clinical condi-tion by the vast majority of physicians.
Instead, it is thought to be either an insignificant finding in an otherwise healthy patient or a …

As the aging population and the incidence of age‐related health conditions increase, the
cost of healthcare is also expected to rise. Anemia commonly occurs in the elderly, and is …

Background Anemia has a myriad of causes and its prevalence is growing. Anemia is
associated with increased all-cause hospitalization and mortality in community-dwelling …

Anemia is common in older people and it becomes more so with advancing decades.
Because the older population is increasing, the prevalence of anemia and consequently its …

Purpose. The incidence, etiology, impact, and considerations in developing guidelines for
treating anemia in patients with cancer are described. Summary. Anemia is common in …